183 related articles for article (PubMed ID: 27832954)
1. Efficient approach to enhance drug solubility by particle engineering of bovine serum albumin.
Khoder M; Abdelkader H; ElShaer A; Karam A; Najlah M; Alany RG
Int J Pharm; 2016 Dec; 515(1-2):740-748. PubMed ID: 27832954
[TBL] [Abstract][Full Text] [Related]
2. The use of albumin solid dispersion to enhance the solubility of unionizable drugs.
Khoder M; Abdelkader H; ElShaer A; Karam A; Najlah M; Alany RG
Pharm Dev Technol; 2018 Sep; 23(7):732-738. PubMed ID: 28771055
[TBL] [Abstract][Full Text] [Related]
3. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
4. New binary solid dispersion of indomethacin with surfactant polymer: from physical characterization to in vitro dissolution enhancement.
Sivert A; Bérard V; Andrès C
J Pharm Sci; 2010 Mar; 99(3):1399-413. PubMed ID: 19827098
[TBL] [Abstract][Full Text] [Related]
5. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
Sun DD; Lee PI
J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
[TBL] [Abstract][Full Text] [Related]
6. Effect of preparation method on the surface properties and UV imaging of indomethacin solid dispersions.
Asare-Addo K; Alshafiee M; Walton K; Ward A; Totea AM; Taheri S; Mawla N; Adebisi AO; Elawad S; Diza C; Timmins P; Conway BR
Eur J Pharm Biopharm; 2019 Apr; 137():148-163. PubMed ID: 30836178
[TBL] [Abstract][Full Text] [Related]
7. Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study.
Bertoni S; Albertini B; Ferraro L; Beggiato S; Dalpiaz A; Passerini N
Eur J Pharm Biopharm; 2019 Jun; 139():132-141. PubMed ID: 30910731
[TBL] [Abstract][Full Text] [Related]
8. Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.
Shi NQ; Wang SR; Zhang Y; Huo JS; Wang LN; Cai JH; Li ZQ; Xiang B; Qi XR
Eur J Pharm Sci; 2019 Mar; 130():78-90. PubMed ID: 30684657
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.
Dontireddy R; Crean AM
Drug Dev Ind Pharm; 2011 Oct; 37(10):1141-9. PubMed ID: 21615280
[TBL] [Abstract][Full Text] [Related]
10. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
Li Y; Rantanen J; Yang M; Bohr A
Eur J Pharm Sci; 2019 Mar; 129():1-9. PubMed ID: 30553059
[TBL] [Abstract][Full Text] [Related]
11. Interdependence of particle properties and bulk powder behavior of indomethacin in quench-cooled molten two-phase solid dispersions.
Semjonov K; Salm M; Lipiäinen T; Kogermann K; Lust A; Laidmäe I; Antikainen O; Strachan CJ; Ehlers H; Yliruusi J; Heinämäki J
Int J Pharm; 2018 Apr; 541(1-2):188-197. PubMed ID: 29481945
[TBL] [Abstract][Full Text] [Related]
12. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
13. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
Fong SY; Ibisogly A; Bauer-Brandl A
Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
[TBL] [Abstract][Full Text] [Related]
14. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
Wang Z; Li Z; Zhang D; Miao L; Huang G
Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
[TBL] [Abstract][Full Text] [Related]
15. Solid-state properties and dissolution behaviour of tablets containing co-amorphous indomethacin-arginine.
Lenz E; Jensen KT; Blaabjerg LI; Knop K; Grohganz H; Löbmann K; Rades T; Kleinebudde P
Eur J Pharm Biopharm; 2015 Oct; 96():44-52. PubMed ID: 26197392
[TBL] [Abstract][Full Text] [Related]
16. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000.
El-Badry M; Fetih G; Fathy M
Saudi Pharm J; 2009 Jul; 17(3):217-25. PubMed ID: 23964164
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique.
Chauhan B; Shimpi S; Paradkar A
AAPS PharmSciTech; 2005 Oct; 6(3):E405-12. PubMed ID: 16353998
[TBL] [Abstract][Full Text] [Related]
18. Freeze-dried amorphous dispersions for solubility enhancement of thermosensitive API having low molecular lipophilicity.
Kulthe VV; Chaudhari PD; Aboul-Enein HY
Drug Res (Stuttg); 2014 Sep; 64(9):493-8. PubMed ID: 24443307
[TBL] [Abstract][Full Text] [Related]
19. Surfactant-Free Solid Dispersions of Hydrophobic Drugs in an Amorphous Sugar Matrix Dried from an Organic Solvent.
Takeda K; Gotoda Y; Hirota D; Hidaka F; Sato T; Matsuura T; Imanaka H; Ishida N; Imamura K
Mol Pharm; 2017 Mar; 14(3):791-798. PubMed ID: 28192663
[TBL] [Abstract][Full Text] [Related]
20. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
